
David S Liebeskind
@dliebesk
Neurovascular
ID: 21123419
http://www.collateralperfusion.org 17-02-2009 19:56:59
239 Tweet
1,1K Followers
124 Following

🎉Registration for the fifth annual #BRAINConference is officially open! 👉Secure your spot today to join us in person or online at etc.venues 155 Bishopsgate, London, on 2-4 December 2024 🧠Topics include #stroke, #aneurysms, new technology and much more!




Congrats to Dr. Tudor G. Jovin, MD & Dr. David S Liebeskind, MD, MBA on the LASTE trial publication! Large core strokes of unrestricted size receiving thrombectomy have favorable patient outcomes to medical care alone. This reinforces the need to increase accessible Thrombectomy worldwide #LASTETrial











David S Liebeskind, MD, MBA asked me to share a few examples of problems on the ground in neurosurgery and my experience of trying to solve them in his new conference. Stop by tomorrow!



AIIMS treats first patient in GRASSROOT stroke trial to evaluate advanced stent-retriever for stroke treatment ethealthworld.com/s/l0ppmyw World Stroke Org Mission Thrombectomy AINA AIIMS, New Delhi 🇮🇳




Neurovascular Innovation at the FDA: Pivotal Strategies to Effectively Modernize the Realization of Diagnostic, Drug, and Device Products | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV… Stroke AHA/ASA SVIN Stroke: Vascular and Interventional Neurology

